Together we can raise the standard of cancer reporting and improve outcomes for cancer patients worldwide.
Pathology reports are needed to guide treatment of individual patients. Structured reporting checklists improve the completeness of cancer reporting by ensuring that all key elements are included in the report, specifically those which have clinical management, staging or prognostic implications.
Patients benefit by having the most effective and timely treatment based on accurate and complete information in their pathology report. Aside from the personal benefits of correct treatment, there are also cost implications for both the patient and public health systems. Standardised cancer datasets are also a prerequisite for national and international benchmarking in cancer monitoring and management.
Member organisations become part of our Dataset Steering Committee, which provides oversight and direction for the development of our datasets, development standards and translations.
Membership fees are used to cover the costs of developing and publishing the cancer datasets, maintaining the ICCR website, financing meetings, and producing publication materials eg articles, posters.
None of the directors on the executive board are paid for the work they do, nor are the wonderful volunteers on our Dataset Authoring Committees.
All fees are devoted to our purpose – the development and publication of cancer datasets for use around the world.